Showing results (241-250 of 291) with videos related to
Sort By:
Pageof 30
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2013
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental GroupRudolph Kirk R Schultz, Kevin Scott Baker, Jaap J Boelens, et al.Leukemia|September 13, 2022
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trialAnna Eichinger, Ulrike Poetschger, Evgenia Glogova, et al.Bone Marrow Transplantation|February 28, 2023
Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) studyDina Averbuch, Rafael de la Camara, Gloria Tridello, et al.Blood|April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosisBernd Hartz, Rebecca Marsh, Kanchan Rao, et al.Haematologica|February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemiaSandra Preuner, Christina Peters, Ulrike Pötschger, et al.Journal of Clinical Immunology|April 21, 2023
The GAIN Registry - a New Prospective Study for Patients with Multi-organ Autoimmunity and AutoinflammationPaulina Staus, Stephan Rusch, Sabine El-Helou, et al.Bone Marrow Transplantation|August 29, 2019
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factorsJan Styczyński, Gloria Tridello, Linda Koster, et al.Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.The Lancet. Oncology|October 14, 2019
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W Laetsch, Gary Douglas Myers, André Baruchel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2022
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA TrialTheodore W Laetsch, Shannon L Maude, Susana Rives, et al.Pageof 30